6533b838fe1ef96bd12a45bf
RESEARCH PRODUCT
LBA9_PR Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiation therapy (CRT): First results of the CheckMate 577 study
Markus MoehlerRonan J. KellySatoru MotoyamaK. GeboesJames M. ClearyLili ZhuHope E. UronisCecile GrootscholtenJarosław KużdżałAstrid LièvreElena ElimovaThomas ZanderJaffer A. AjaniJoshua ZhangKaoru KondoGuillaume PiessenMing LeiGuillermo MendezJosephine FelicianoE. Van Cutsemsubject
Oncologymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentCheckmateCancerHematologymedicine.diseaseGastroesophageal JunctionOncologyInternal medicinemedicineNivolumabbusinessAdjuvantyear | journal | country | edition | language |
---|---|---|---|---|
2020-09-01 | Annals of Oncology |